RJ

Robert Johnson

Chief Executive Officer

Kesmalea Therapeutics

Cambridge, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Kesmalea Therapeutics
Industry
research
Employees
24.0
Seniority
C suite

Technologies

Outlook Google Cloud Hosting WordPress.org Mobile Friendly Nginx Circle

Keywords

biotechnology research protein degradation novel therapeutics oral bioavailability cns penetration targeted protein degradation bifunctional degraders modular design selftac platform small molecules clinical viability oncology central nervous system drug discovery medicinal chemistry chronic diseases biotech collaboration therapeutic investment in-house development biopharma synthetic rescue gene therapy aav capsids pharmaceutical strategy investor collaboration research & development translational research small biotech clinical trials drug candidate immunology early clinical development phase 2 studies drug discovery leadership biotechnology life sciences genetically driven diseases biopharmaceuticals orally administered drugs therapeutic approaches innovative medicines drug discovery strategies collaborative environment market entry facilitation biotechnology expertise investment management pharmacology business development portfolio management hospital & health care health care health wellness & fitness financial services b2b

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans